abstract |
Novel 1,2-dihydro-2-oxo-3-methylsulphonylaminomethylpyridines of the formula I <IMAGE> wherein R<1> is alkyl having 1-5 C atoms, R<2> is CN or 1H-tetrazol-5-yl and R<3> is alkyl having 1-5 C atoms or cyclopropylmethyl, and their salts show angiotensin II-antagonistic properties and can be used for the treatment of hypertension, aldosteronism and cardiac insufficiency. |